The benchmark indices extended their northward journey for the second straight session, climbing decisively above 25,200 with a 0.8 percent gain on June 25. The market breadth remained positive, with approximately 1,957 shares advancing compared to 654 declining shares on the NSE. Given the favourable technical indicators, the uptrend is likely to continue in the upcoming sessions. Below are some ...

The market cut down losses due to buying interest in the second half and finished the session 27 points lower on March 12. The market breadth has consistently been favouring bears, which is negative. About 1,736 shares were under pressure, compared to 885 shares that gained on the NSE. The benchmark indices are likely to be rangebound in the upcoming sessions. Below are some trading ideas for the ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and fund-raising, here’s a quick look at which stocks will be in focus in today's trade:Results TodayGodavari Biorefineries, Waaree Energies, Valecha Engineering, and Samyak International will release quarterly earnings on November 18.Quarterly EarningsHero MotoCorp Q2 (Stand...

And just like that, the House of Cards came crashing down on October 3 as benchmark indices plunged deep into the red, rattled by Iran’s launch of ballistic missiles at Israel, sparking fears of retaliation and escalation in the war. But is this another false fall, destined to be propped up by the familiar 'buy on dips'?The geopolitical tinderbox is now the biggest threat to global equities, war...

Crompton & HAVells both rallied 20-25% in Q2 on expected synergies from Butterfly/B2B pick-up respectively. Softening commodities have fueled hopes of margin recovery in Q2, given the 10-15% price hikes in last four quarters. Butterfly integration is a key catalyst for Crompton. Weak margin in Lloyd is a key risk for Havells, while its core business is doing better. In FY23-25, we expect Cromptonâ...